Similar articles

• [Anti-Helicobacter pylori quadruple therapy].

  Fukuda Y, Sakagami T. Fukuda Y, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:442-51. Nihon Rinsho. 2005. PMID: 16363576 Review. Japanese. No abstract available.
• [Adverse effects of Helicobacter pylori eradication and its prevention].

  Zhang S, Yanaka A. Zhang S, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:414-7. Nihon Rinsho. 2005. PMID: 16363570 Review. Japanese. No abstract available.
• [Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].

  Kobayashi K, Fujishiro M, Omata M, Oka M. Kobayashi K, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:459-60. Nihon Rinsho. 2005. PMID: 16363578 Review. Japanese. No abstract available.
• [Helicobacter pylori eradication therapy for children].

  Konno M. Konno M. Nihon Rinsho. 2005 Nov;63 Suppl 11:470-3. Nihon Rinsho. 2005. PMID: 16363581 Review. Japanese. No abstract available.
• Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.

  Fennerty MB. Fennerty MB. Am J Gastroenterol. 1998 Jan;93(1):2-3. doi: 10.1111/j.1572-0241.1998.002_c.x. Am J Gastroenterol. 1998. PMID: 9448162 Clinical Trial. No abstract available.